Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunjan Sinha

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|November 17, 2022
Tumors can teem with microbes. But what are they doing there?Gunjan Sinha
Nature Biotechnology|July 9, 2014
Sanofi's dengue vaccine first to complete phase 3Gunjan Sinha
Journal of the National Cancer Institute|July 10, 2014
Decision aids help patients but still are not widely usedGunjan Sinha
Journal of the National Cancer Institute|July 26, 2013
Immunotherapy to treat leukemia possibly ineffective for advanced diseaseGunjan Sinha
Nature|March 3, 2017
Hunted, haunted, stateless and scared: the stories of refugee scientistsGunjan Sinha
Nature Medicine|May 6, 2006
Cell-based tests tackle predicting safety of antibody drugsGunjan Sinha
Journal of the National Cancer Institute|August 17, 2006
European move affects academic trials researchGunjan Sinha
Nature Medicine|September 9, 2006
Drug companies accused of stalling tailored therapiesGunjan Sinha
Scientific American|August 10, 2004
Outsourcing drug work. Pharmaceuticals ship R&D and clinical trials to IndiaGunjan Sinha
Nature Medicine|January 7, 2005
Medicine of the massesGunjan Sinha
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|November 17, 2022
Tumors can teem with microbes. But what are they doing there?Gunjan Sinha
Nature Biotechnology|July 9, 2014
Sanofi's dengue vaccine first to complete phase 3Gunjan Sinha
Journal of the National Cancer Institute|July 10, 2014
Decision aids help patients but still are not widely usedGunjan Sinha
Journal of the National Cancer Institute|July 26, 2013
Immunotherapy to treat leukemia possibly ineffective for advanced diseaseGunjan Sinha
Nature|March 3, 2017
Hunted, haunted, stateless and scared: the stories of refugee scientistsGunjan Sinha
Nature Medicine|May 6, 2006
Cell-based tests tackle predicting safety of antibody drugsGunjan Sinha
Journal of the National Cancer Institute|August 17, 2006
European move affects academic trials researchGunjan Sinha
Nature Medicine|September 9, 2006
Drug companies accused of stalling tailored therapiesGunjan Sinha
Scientific American|August 10, 2004
Outsourcing drug work. Pharmaceuticals ship R&D and clinical trials to IndiaGunjan Sinha
Nature Medicine|January 7, 2005
Medicine of the massesGunjan Sinha
Pageof 8